European Drug Development: A Masterclass

Join Alacrita at the CIC in Kendall Square on January 29th, 2019, for an educational session on European drug development and commercialization. You will learn about valuable insight into most...
Learn More

Meet Alacrita at JPM 2019!

The Alacrita team will be attending and sponsoring Biotech Showcase at JPM 2019 in San Francisco this January 7–9, 2019, at the Hilton San Francisco Union Square. This is always one of the industry's...
Learn More

Peter G. Traber to speak at Discovery on Target’s 2nd Annual NASH and Fibrosis conference in Boston

Discovery on Target’s 2nd Annual NASH and Fibrosis conference will be held in Boston, MA on September 26 and 27, 2018 and promises to be an important event in the very hot NASH drug development...
Learn More

Alacrita Appoints Peter Traber to Lead Consulting on Anti-fibrotic Drug Development

Alacrita is pleased to announce the appointment of Peter G. Traber, MD, as Partner in its Waltham, MA office. Peter is a distinguished scientist and gastroenterologist/hepatologist with over 30 years...
Learn More

Alacrita Appoints Anna Casse as 4th Managing Partner To Strengthen Commercial Advisory Services and Build a European Launch Platform

Alacrita, the transatlantic life science consulting firm, today announced the appointment of Anna Casse BSc, MBA as Managing Partner. Anna joins Alacrita from BioVault, where she was the CEO,...
Learn More

European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR)

The final texts of the greatly anticipated European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR) have just been published in the Official Journal of the European...
Learn More

Alacrita Medical Imaging Consultant Presenting at International Osteoarthritis Conference

Cambridge, MA, – May 2016 – Alacrita, the life sciences consulting firm, today announced that medical imaging expert and Alacrita Partner, Colin G Miller PhD, will present a poster at the upcoming...
Learn More

Edward Garmey MD will moderate a panel at BIO-Europe

On March 20th, Alacrita Partner Edward Garmey, M.D., will moderate a distinguished panel titled “Clinical trials in early stage oncology development” at the 11th annual BIO-Europe Spring conference...
Learn More

Alacrita offers asset scouting services

Alacrita is proud to offer asset scouting services. Please read below to learn about an ongoing project.
Learn More

Simon Turner and Anthony Walker attending Biotech and Money, London

Simon Turner PhD and Anthony Walker PhD, Managing Partners, are attending Biotech and Money on February 7-8 in London UK.
Learn More

Alacrita attending JPMorgan, Biotech Showcase

Led by Managing Partners Rob Johnson and Simon Turner, Alacrita is attending the 35th Annual J.P. Morgan Healthcare Conference and Biotech Showcase which take place January 9th through 13th.
Learn More

Bill Slichenmyer, Alacrita Partner, reflects on SITC 2016 conference

Reflections on SITC 2016 (Part 2)
Learn More
1 2 3 4 5